Skip to main content
Update Location

My Location

Update your location to show providers, locations, and services closest to you.

Enter a zip code
Or
Select a campus/region

All results

8 results for multicenter prospective randomized subject and evaluator blinded comparative study

  • Bio-BOOST

    BioBOOST is a multicenter, observational study of the effect of derangements in brain physiologic parameters on brain injury biomarker levels in patients with…

    Ages
    18 Years - N/A
    Sexes
    All
  • ENRICH-US

    The institution of perioperative Enhanced Recovery Protocols (ERPs) has been found to decrease hospital length of stay, in-hospital costs, and complications…

    Ages
    10 Years - 18 Years
    Sexes
    All
  • ReCePI

    The objective of this study is to evaluate the efficacy and safety of RBC transfusion for support of acute anemia in cardiovascular surgery patients based on…

    Ages
    11 Years - N/A
    Sexes
    All
  • CardiAMP

    This is a prospective, multi-center, randomized, controlled, patient* and evaluator-blinded study comparing treatment with the CardiAMP cell therapy to a sham…

    Ages
    21 Years - 90 Years
    Sexes
    All
  • Saturn

    The SATURN trial aims to determine whether continuation vs. discontinuation of statin drugs after spontaneous lobar intracerebral hemorrhage (ICH) is the best…

    Ages
    50 Years - N/A
    Sexes
    All
  • Teton RIN-PF-301

    Study RIN-PF-301 is designed to evaluate the superiority of inhaled treprostinil against placebo for the change in absolute forced vital capacity (FVC) from…

    Ages
    40 Years - N/A
    Sexes
    All
  • TETON

    Study RIN-PF-301 is designed to evaluate the superiority of inhaled treprostinil against placebo for the change in absolute forced vital capacity (FVC) from…

    Ages
    40 Years - N/A
    Sexes
    All
  • Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD (WARRIOR)

    The Ischemia-IMT (Ischemia-Intensive Medical Treatment Reduces Events in Women with Non-Obstructive CAD), subtitle: Women's Ischemia Trial to Reduce Events in…

    Ages
    18 Years - 100 Years
    Sexes
    Female